You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alemtuzumab

Showing 26 - 50 of 145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)

Completed
Has Results
  • Renal Transplantation
  • Alemtuzumab
  • +5 more
  • San Francisco, California
  • +7 more
Jul 8, 2021

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

Active, not recruiting
  • Sickle Cell Disease
  • Beta Thalassemia
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

Terminated
  • Epidermolysis Bullosa
  • Aurora, Colorado
  • +2 more
Aug 13, 2021

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

Recruiting
  • Systemic Sclerosis
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Dec 17, 2021

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
Has Results
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • La Jolla, California
  • +2 more
Jul 29, 2020

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Alemtuzumab
  • +2 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +4 more
  • alemtuzumab
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
Jun 11, 2020

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (Alemtuzumab)

Completed
  • Allogeneic Hematopoietic Cell Transplantation
  • Alemtuzumab
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 3, 2019

Organ Transplantation Trial in Atlanta (Belatacept, Sirolimus, Alemtuzumab)

Completed
Has Results
  • Organ Transplantation
  • Atlanta, Georgia
  • +1 more
Jan 30, 2020

Evidence of Liver Transplantation, Rejection, ALEMTUZUMAB Trial (Alemtuzumab)

Completed
Has Results
  • Evidence of Liver Transplantation
  • +2 more
  • Alemtuzumab
  • (no location specified)
Jul 1, 2019

Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

Completed
  • Ewing Sarcoma
  • +12 more
  • alemtuzumab
  • +6 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 14, 2020

Acute Lymphoblastic Leukemia Trial in United Kingdom (Fludarabine, Melphalan, Alemtuzumab)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Birmingham, United Kingdom
  • +21 more
Oct 14, 2021

Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)

Active, not recruiting
  • Sickle Cell Disease
  • Oakland, California
  • +34 more
Sep 21, 2022

Chronic Lymphocytic Leukemia Trial in Austria, France, Germany (Alemtuzumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Wien, Austria
  • +37 more
Oct 21, 2019

Immunodeficiency Syndrome, Non-Cancer Diagnosis Trial in United States (biological, procedure, drug, other, radiation)

Completed
Has Results
  • Immunodeficiency Syndrome
  • Non-Cancer Diagnosis
  • Alemtuzumab
  • +7 more
  • Oakland, California
  • +5 more
Feb 5, 2020

Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

Recruiting
  • Chronic Myeloid Leukemia (CML)
  • +5 more
  • CliniMACS CD34+ Reagent System
  • +8 more
  • New York, New York
    Columbia University Medical Center
Jun 17, 2020

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
Has Results
  • Myeloid Malignancy
  • +5 more
  • Alemtuzumab
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020

Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)

Terminated
  • Multiple Sclerosis
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Apr 26, 2019

Crohn's Disease Trial in Chicago (Fludarabine, Cyclophosphamide, Mesna)

Withdrawn
  • Crohn's Disease
  • Chicago, Illinois
    Northwestern University
Nov 6, 2019